Ivax Confident On Flonase Generic In 2004, Despite Bioequivalence Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
Chicago law firm submits petition asking FDA to enforce standards in 2003 draft guidance on nasal inhalers. Client is unidentified, but is not GlaxoSmithKline. Ivax continues to expect approval of ANDA for fluticasone nasal spray this year.